You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC

https://doi.org/10.1136/jitc-2021-004197corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Frigola J, Carbonell C, Iranzo P, et al. High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC. J ImmunoTher Cancer 2022;10:e004197. doi: 10.1136/jitc-2021-004197

    This article has been corrected since it was first published online. Author name ‘Patricia Irazno’ has been corrected to ‘Patricia Iranzo’.